M3 Global Research

What M3 Global Research does

M3 Global Research is a healthcare-focused market research fieldwork and panel services provider operating as a wholly-owned division of M3 Inc., a Japanese company listed on the Tokyo Stock Exchange (joined the NIKKEI 225 in 2019, ranked in Forbes' 2020 Global 2000 and Fortune's 2020 Future 50). The company recruits verified healthcare professionals and patients for qualitative and quantitative market research studies, serving global pharmaceutical, biotechnology, and life sciences enterprises, as well as healthcare-specialized market research agencies that outsource fieldwork and panel recruitment. The company was incorporated as part of M3 Inc. (founded 2000), with operating headquarters in Fort Washington, Pennsylvania (United States) and London (United Kingdom).

The core assets are two proprietary panels — the M3 Physician Panel, described as the world's largest provider panel of verified HCPs, and the M3 Patient Panel — collectively reaching 6.2M+ healthcare professionals across 70+ markets, with 805,560 lifetime survey completes recorded. The company layers proprietary technology on top of panel access, including QualStage (qualitative research staging platform), QuickCharts (data visualization tool), M3TEOR (methodology and technology framework), and Fraud Prevention (data integrity module). The panel infrastructure is ISO 20252 certified and information security is ISO 27001 certified, with annual PwC audits. Beyond the US and UK, M3 Global Research has expanded into continental Europe through acquired subsidiaries Med Planet (France, acquired April 2023) and pharma-insight (Germany).

M3 Global Research generates revenue through project-based professional services engagements priced on a quote/bid basis (a "Request a Bid" CTA gates the sales funnel). Distribution is delivered through enterprise field sales and inside sales teams based in the US and UK, targeting pharmaceutical, biotech, and healthcare market research buyers across global markets. The company is not separately capitalized as a venture-backed or PE-owned entity; financing and strategy flow through parent company M3 Inc., whose public listing provides scale and credibility benefits for enterprise sales motions.

Name

M3 Global Research

Legal name

M3 Global Research

Website

https://m3global.com

Company type

Public

Founded year

2000

Operating status

Operating

Headcount range

51–100 employees

Short description

M3 Global Research provides healthcare market research fieldwork and recruitment services through its proprietary panel of 6.2M+ verified physicians and patients across 70+ markets, serving global pharmaceutical, biotechnology, and healthcare research agency clients with qualitative and quantitative research support.

Ownership category

akta.pro rank

Product category

Healthcare Market Research Services

NAICS

Other Scientific and Technical Consulting Services (54169), Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000)

akta.pro primary industry

Industry & Sector Research (Syndicated/Custom) (BPAHALAE)

akta.pro secondary industry

Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)

Keywords

• Healthcare market research
• Physician panel recruitment
• Qualitative fieldwork services
• Quantitative survey research
• Patient panel research

Headquarters

HQ city

Fort Washington

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Healthcare Market Research Services: M3 Global Research generates revenue by providing quantitative and qualitative market research services to pharmaceutical, biotech, and healthcare companies. Services are project-based and scoped through enterprise bid requests, typically involving panel access, recruitment, programming, data processing, and fieldwork across global markets.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Core offering

M3 Global Research provides project-based healthcare market research fieldwork services to pharmaceutical, biotechnology, and life sciences companies and healthcare-focused market research agencies. Its core offering combines a proprietary verified healthcare professional and patient panel of 6.2 million-plus members across 70-plus markets with qualitative research (in-person and remote) and quantitative research (survey programming, data processing, and fraud prevention), delivered through enterprise bid-based engagements.

Product overview

M3 Global Research operates as a unified healthcare market research platform combining proprietary panels with technology-enabled research methodologies. The core offering centers on two panel products—M3 Physician Panel (world's largest verified HCP panel) and M3 Patient Panel—serving as the foundation for two primary research service lines: Qualitative Research and Quantitative Research. Technology sub-products including QualStage, QuickCharts, and M3TEOR layer across both service lines to enable research design, execution, and analysis. Add-on quality modules such as Fraud Prevention and Programming & Data Processing extend the quantitative offering. All services are delivered through a global reach of over 6.2 million healthcare professionals across 70+ markets.

Differentiator

Problem solved

Functional benefit

Brands

• M3 Physician Panel: Proprietary provider panel of verified healthcare professionals - world's largest physician panel
• M3 Patient Panel
• QualStage
• M3TEOR

Products and services

• M3 Physician Panel Proprietary provider panel of verified healthcare professionals (HCPs), described as the world's largest, enabling robust quantitative and qualitative healthcare market research projects in over 70 markets for pharmaceutical, biotech, and healthcare research clients.
• M3 Patient Panel Proprietary patient panel enabling patient-centric healthcare research alongside the physician panel to deliver comprehensive healthcare insights for pharma, biotech, and life sciences clients.
• Qualitative Research Services Full-service qualitative healthcare market research delivered through remote and in-person methodologies, underpinned by targeted recruitment from the M3 Panel and supported by QualStage, QuickCharts, and M3TEOR for pharma, biotech, and healthcare research clients.
• Quantitative Research Services Volume-based quantitative healthcare market research leveraging the ISO-certified proprietary panel of verified HCPs and patients to deliver actionable insights, with integrated survey programming, data processing, QuickCharts, M3TEOR, and Fraud Prevention capabilities.

Quantifiable outcome

• 6,200,000 global HCP reach across 70+ markets
• +3 more outcomes

Named customers4 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core.

• Med PlanetcoreStrategic or Co-development Partner · 17 April 2023M3 Global Research acquired French research agency Med Planet to strengthen its presence in Europe and the life sciences sector. Med Planet, based in Lyon and established in 1997, continues to operate under its current leadership.
• Med PlanetcoreStrategic or Co-development Partner · 12 April 2023M3 Global Research acquired Med Planet, a French qualitative research services provider, on April 12, 2023. The purchase aims to strengthen M3's presence and capabilities in the European healthcare market, especially in France. This follows M3's previous acquisition of Germany's pharma-insight and is part of broader global growth initiatives.
• Med PlanetcoreStrategic or Co-development PartnerM3 Global Research acquired Med Planet on April 12, 2023. Med Planet, a French qualitative research services provider based in Lyon and established in 1997, continues to operate under its current leadership. The acquisition strengthens M3's presence and capabilities in the European healthcare market, especially in France, and follows M3's previous acquisition of Germany's pharma-insight as part of broader global growth initiatives.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Schlesinger Group: Global qualitative research services provider running in-person and remote qualitative studies with panel recruitment. Highly comparable to the qualitative side of M3 Global Research's offering, including platform-supported qualitative workflows.
• Toluna: Online panel and survey technology provider serving consumer and B2B market research buyers. Comparable to M3 Global Research on the large-panel, technology-enabled quantitative research axis, though Toluna is broader across industries.
• Clarivate (Decision Resources Group): Provides syndicated and custom healthcare market research and analytics to pharma and life sciences clients. Closely comparable to M3 Global Research in both the panel/fielwork angle and the custom insights deliverable to enterprise pharma buyers.
• Dynata: Large first-party data and panel-based market research provider. Comparable to M3 Global Research in operating a global verified panel, programming capabilities, and data processing services for research buyers.
• Medscape (WebMD/Internet Brands): Large verified physician member base used both for clinical content and market research panels. Comparable to M3 Global Research on the physician-panel supply side, serving overlapping pharma clients seeking HCP insights.

Emerging players

• GLG (Gerson Lehrman Group): Expert network providing on-demand consultations with healthcare professionals for primary research. Comparable to M3 Global Research's expert-interview component, focused on healthcare verticals, though operating with a different delivery model.

Broad incumbents

• IQVIA: Global leader in healthcare data, analytics, and market research serving pharma and biotech. Highly comparable to M3 Global Research because both monetize healthcare professional insight at scale, though IQVIA bundles research within a much broader clinical and commercial data portfolio.
• Kantar: Large multinational market research firm with a healthcare research division serving pharma and biotech on custom and syndicated insights. Comparable to M3 Global Research in custom HCP research design and panel-based quantitative work.
• Ipsos: Global market research group with a dedicated healthcare practice running both qualitative and quantitative studies for pharma clients. Direct overlap with M3 Global Research in custom HCP fieldwork, though Ipsos operates across many non-healthcare verticals.
• GfK (now NIQ): Global market research firm with consumer and healthcare research practices. Comparable to M3 Global Research for multi-country fieldwork and custom research execution, though broader across non-healthcare categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/m3globalrsrch

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about M3 Global Research